Survey Doctor is looking for beta testers 25% off with code SD2026

DASS-21 vs PHQ-9: Choosing the right screening tool

One measures depression alone. The other measures depression, anxiety, and stress in a single sitting. Here's how to decide which fits your clinical or personal needs.

A patient walks into a primary care appointment reporting low mood and trouble sleeping. The clinician needs to quantify the severity quickly. Should they reach for the PHQ-9 -- the nine-item depression standard -- or the DASS-21, which covers depression, anxiety, and stress in one 21-item questionnaire?

It's a fair question. Both are validated, widely used, and free. But they were built for different purposes, measure different things, and work best in different situations. Choosing between the DASS-21 and the PHQ-9 starts with understanding what each tool is actually doing under the hood.

Side-by-side comparison

Feature[PHQ-9](/surveys/phq9)[DASS-21](/surveys/dass21)
**Full name**Patient Health Questionnaire-9Depression Anxiety Stress Scales - 21
**Items**921 (7 per subscale)
**What it measures**Depression severityDepression, anxiety, and stress (3 subscales)
**Response scale**0-3 (frequency-based)0-3 (degree of applicability)
**Score range**0-27 (total)0-42 per subscale (after doubling)
**Timeframe**Past 2 weeksPast week
**Scoring**Sum of all itemsSum per subscale, multiplied by 2
**Clinical cutoff (depression)**1010 (depression subscale, after doubling)
**DSM alignment**Direct (maps to 9 DSM criteria)Indirect (dimensional, not DSM-based)
**Developed**2001 (Kroenke, Spitzer, Williams)1995 (Lovibond & Lovibond)
**Primary setting**Primary care screeningResearch, clinical psychology
**Cost**FreeFree with attribution

What each tool actually measures

The PHQ-9: A focused depression lens

The PHQ-9 is a single-construct instrument. Every one of its nine items corresponds to a DSM criterion for major depressive disorder:

- Anhedonia (loss of interest or pleasure)
- Depressed mood (feeling down, depressed, hopeless)
- Sleep problems (too little or too much)
- Fatigue (tired, low energy)
- Appetite changes (poor appetite or overeating)
- Self-worth (feeling like a failure)
- Concentration (trouble focusing)
- Psychomotor changes (moving or speaking too slowly/quickly)
- Suicidal ideation (thoughts of self-harm)

This DSM alignment is the PHQ-9's defining feature. It doesn't just tell you someone is distressed -- it tells you they're experiencing symptoms that map onto a specific diagnostic category. That makes it clinically actionable in a way that dimensional measures aren't.

The PHQ-9 also includes a functional assessment question: "How difficult have these problems made it for you to do your work, take care of things at home, or get along with other people?" This item isn't scored, but it adds critical context about real-world impact.

The DASS-21: Three dimensions in one instrument

The DASS-21 takes a fundamentally different approach. It measures three related but distinct emotional states, each through seven items:

Depression subscale (items 3, 5, 10, 13, 16, 17, 21):
- Inability to experience positive feelings
- Difficulty initiating activities
- Nothing to look forward to
- Feeling down-hearted and blue
- Unable to become enthusiastic
- Low self-worth
- Life feeling meaningless

Anxiety subscale (items 2, 4, 7, 9, 15, 19, 20):
- Dryness of mouth
- Breathing difficulty
- Trembling
- Worry about panicking
- Close to panic
- Heart awareness without exertion
- Feeling scared without reason

Stress subscale (items 1, 6, 8, 11, 12, 14, 18):
- Difficulty winding down
- Over-reacting to situations
- Using a lot of nervous energy
- Getting agitated
- Difficulty relaxing
- Intolerance of interruptions
- Feeling touchy

Notice something important about these groupings. The DASS-21's depression subscale focuses heavily on anhedonia and low positive affect -- the inability to experience pleasure, motivation, or meaning. This is different from the PHQ-9, which covers the full DSM symptom spectrum including sleep, appetite, concentration, and suicidal ideation.

The DASS-21's anxiety subscale emphasizes physical arousal and panic -- trembling, breathing difficulty, heart pounding. This is closer to panic disorder than the cognitive worry pattern measured by the GAD-7.

The stress subscale captures tension, irritability, and difficulty relaxing -- constructs that overlap with anxiety but are conceptually distinct. This third dimension is unique to the DASS-21 and has no equivalent in the PHQ family.

Scoring differences that matter

PHQ-9 scoring

The PHQ-9 asks how often you've experienced each symptom ("Not at all" to "Nearly every day"). You sum all nine items for a total between 0 and 27. Five severity bands map directly to clinical action:

ScoreSeverityClinical action
0-4MinimalNone
5-9MildWatchful waiting
10-14ModerateConsider treatment
15-19Moderately severeActive treatment
20-27SevereImmediate treatment

At a cutoff of 10, the PHQ-9 achieves 88% sensitivity and 88% specificity for major depression (Kroenke et al., 2001). A 5-point change is clinically meaningful.

DASS-21 scoring

The DASS-21 asks how much each statement applied to you over the past week ("Did not apply to me at all" to "Applied to me very much, or most of the time"). You sum the seven items in each subscale, then multiply by 2 to match the norms from the original 42-item DASS.

This doubling step is critical. Without it, you'll underestimate severity.

Depression subscale (after doubling):

ScoreSeverity
0-9Normal
10-13Mild
14-20Moderate
21-27Severe
28+Extremely severe

Anxiety subscale (after doubling):

ScoreSeverity
0-7Normal
8-9Mild
10-14Moderate
15-19Severe
20+Extremely severe

Stress subscale (after doubling):

ScoreSeverity
0-14Normal
15-18Mild
19-25Moderate
26-33Severe
34+Extremely severe

The DASS-21 severity labels describe where someone falls in the population distribution, not whether they meet clinical diagnostic criteria. This is a fundamental difference from the PHQ-9.

Key conceptual differences

Diagnostic vs dimensional

The PHQ-9 was designed as a diagnostic tool. It maps to DSM criteria, supports provisional diagnosis through an algorithm (if items 1 or 2 are endorsed at "more than half the days" and five or more items meet that threshold), and produces severity categories that link directly to treatment recommendations.

The DASS-21 was designed as a dimensional measure of emotional distress. It describes where someone falls on three continua. Lovibond and Lovibond explicitly stated that the DASS measures emotional states, not clinical diagnoses. The severity labels ("normal," "mild," "moderate," "severe," "extremely severe") describe statistical positions in the population, not diagnostic thresholds.

This distinction matters for clinical decision-making. A PHQ-9 score of 15 comes with a specific recommendation: "Active treatment with pharmacotherapy and/or psychotherapy." A DASS-21 depression score of 21 tells you the person is in the "severe" range -- but the clinical pathway isn't as directly prescribed.

Breadth vs depth

The PHQ-9 goes deep on one construct. Nine items, all targeting depression, with coverage of the full diagnostic picture including somatic symptoms (sleep, appetite, energy, psychomotor changes) and the critical suicidal ideation item.

The DASS-21 goes broad across three constructs. Seven items each for depression, anxiety, and stress. This breadth comes at a cost: each individual subscale is less thorough than a dedicated single-construct tool. The depression subscale, for example, doesn't include sleep, appetite, concentration, or suicidal ideation -- all of which appear on the PHQ-9.

Suicidal ideation coverage

This is a practical difference that clinicians should weigh carefully. The PHQ-9's item 9 ("Thoughts that you would be better off dead or of hurting yourself in some way") provides a direct suicidal ideation screen. Any positive endorsement triggers clinical follow-up regardless of total score.

The DASS-21 has no equivalent item. It does not screen for suicidal ideation. If this is a clinical need -- and in most settings it is -- the DASS-21 requires supplementation.

Response format nuances

The PHQ-9 asks about frequency: How often have you been bothered by this in the past two weeks? The response options are temporal ("Not at all," "Several days," "More than half the days," "Nearly every day").

The DASS-21 asks about applicability/intensity: How much did this statement apply to you over the past week? The response options are about degree ("Did not apply to me at all," "Applied to me to some degree," "Applied to me to a considerable degree," "Applied to me very much").

These are subtly different cognitive tasks. The PHQ-9 asks patients to estimate the number of days they experienced something. The DASS-21 asks them to rate how strongly something applied. Frequency-based items tend to be more concrete and reliable; applicability-based items may capture intensity better.

When to choose the PHQ-9

Primary care screening. The PHQ-9 was developed for and validated in primary care. It's the tool most guidelines recommend for routine depression screening. The USPSTF, APA, and most national guidelines reference the PHQ-9 specifically.

When you need a depression diagnosis. If the goal is to determine whether someone meets criteria for major depressive disorder, the PHQ-9's DSM alignment gives it a clear advantage. Its diagnostic algorithm can support a provisional diagnosis.

Treatment monitoring. The PHQ-9's well-established change thresholds (5-point drop = clinically meaningful) and its recommendation of administration every 2-4 weeks during treatment make it the standard for tracking antidepressant and therapy response.

When suicidal ideation screening is needed. Item 9 provides this. The DASS-21 does not.

When brevity matters most. Nine items is shorter than 21. In high-volume primary care settings, those extra minutes add up across hundreds of patients.

When you need to communicate with other providers. The PHQ-9 is the common language of depression screening. If you're referring a patient to psychiatry, reporting to an insurer, or participating in quality metrics programs, PHQ-9 scores are universally understood.

When to choose the DASS-21

When the presentation is mixed or unclear. A patient reports feeling "terrible" but can't articulate whether it's sadness, worry, or stress. The DASS-21's three subscales help tease apart what's driving the distress -- and the answer is often "all three, but in different proportions."

Research settings. The DASS-21 is widely used in clinical research, particularly in cognitive behavioral therapy studies. Its three-factor structure makes it useful for examining how interventions affect depression, anxiety, and stress independently.

When you want to understand the full emotional picture. Getting depression, anxiety, and stress scores from a single 21-item instrument is efficient. The alternative -- administering the PHQ-9 and the GAD-7 -- gives you 16 items covering two constructs. The DASS-21 gives you 21 items covering three.

Psychology and counseling settings. The DASS-21 was developed in a psychology research context and is more commonly used in psychological practice than in medical settings. Therapists who take a dimensional, transdiagnostic approach to emotional distress often prefer it.

When stress is a relevant dimension. The DASS-21 is the only validated brief measure that separates stress from anxiety. For populations where stress is a primary concern -- caregivers, students during exam periods, people in high-pressure jobs -- the stress subscale adds unique information.

When you want to distinguish physical from cognitive anxiety. The DASS-21's anxiety subscale emphasizes autonomic arousal (trembling, breathing difficulty, heart awareness). This is conceptually different from the cognitive worry captured by the GAD-7. Both perspectives are clinically useful.

Head-to-head on depression detection

How do the two tools compare specifically for detecting depression?

The PHQ-9 has stronger evidence as a depression screener. Its 88% sensitivity and 88% specificity at a cutoff of 10 come from the original validation by Kroenke et al. (2001), replicated across numerous populations and languages.

The DASS-21 depression subscale was not originally designed or validated as a clinical screener, and its psychometric properties for detecting major depressive disorder are less extensively studied. Research suggests the DASS-21 depression subscale correlates moderately to strongly with the PHQ-9 (typically r = 0.70-0.80), but there are important differences in what they capture.

Because the DASS-21 depression subscale focuses on anhedonia and low positive affect, it may miss patients whose depression manifests primarily through somatic symptoms -- fatigue, sleep disruption, appetite changes, psychomotor slowing. The PHQ-9 catches these.

Conversely, the DASS-21 depression subscale includes items about meaninglessness and hopelessness ("I felt that life was meaningless") that reflect existential aspects of depression not directly assessed by the PHQ-9.

Using both tools together

Some clinicians administer both, particularly in psychology and psychiatry settings. This isn't redundant -- it's complementary:

- The PHQ-9 provides a DSM-aligned severity score with clear treatment thresholds and suicidal ideation screening
- The DASS-21 provides a dimensional profile showing the relative contributions of depression, anxiety, and stress

Together, they answer different questions. The PHQ-9 answers "How severe is this person's depression, and does it warrant treatment?" The DASS-21 answers "What's the emotional picture, and how do depression, anxiety, and stress interact in this person?"

If time allows only one, make the choice based on your setting and purpose. If you need a clinical depression screen with treatment guidance, use the PHQ-9. If you need a broad emotional assessment with subscale differentiation, use the DASS-21.

For individuals: Which should you take?

If you're trying to understand your own mental health, here's a simple guide:

Take the PHQ-9 if you suspect depression specifically. It gives you a clear severity score with established clinical meaning, and it includes a suicidal ideation check that could prompt an important conversation with a provider.

Take the DASS-21 if you're not sure what you're feeling. Is it depression? Anxiety? Stress? All three? The DASS-21's three subscales can help you understand the pattern. This is especially useful if you're going to bring results to a therapist -- it gives them three data points instead of one.

Take both if you want the most complete self-assessment. The PHQ-9 gives you a precise depression score with clinical anchors. The DASS-21 gives you the broader context. Together, they take about 8-10 minutes and provide a substantial amount of information.

Regardless of which you choose, remember: these are screening tools, not diagnoses. Elevated scores are information to bring to a provider, not conclusions to carry alone.

Common questions

Is the DASS-21 depression subscale interchangeable with the PHQ-9?

No. While they correlate moderately, they measure overlapping but different aspects of depression. The PHQ-9 covers the full DSM symptom picture; the DASS-21 depression subscale focuses on anhedonia and low positive affect. They should not be used interchangeably, and scores from one cannot be directly converted to the other.

Why does the DASS-21 require multiplying scores by 2?

The DASS-21 is the short form of the 42-item DASS. To maintain comparability with the published severity norms and research base established with the full DASS, subscale scores are doubled. Skipping this step results in underestimated severity.

Can the DASS-21 replace both the PHQ-9 and GAD-7?

Not cleanly. The DASS-21's anxiety subscale emphasizes physical arousal symptoms, while the GAD-7 captures cognitive worry -- they're measuring different facets of anxiety. And the DASS-21's depression subscale omits somatic symptoms and suicidal ideation that the PHQ-9 includes. The DASS-21 provides a useful overview, but it doesn't fully substitute for purpose-built screening tools.

Which is better validated?

Both are well-validated, but in different contexts. The PHQ-9 has more extensive evidence in clinical screening settings, with thousands of validation studies across populations, languages, and medical conditions. The DASS-21 has strong evidence in research and clinical psychology settings, with solid factorial validity supporting its three-factor structure.

My DASS-21 depression score is high but my PHQ-9 score is moderate. How is that possible?

This can happen because the tools weight different symptoms. If your depression manifests mainly as anhedonia and loss of meaning (DASS-21 strengths) rather than sleep, appetite, and concentration problems (PHQ-9 strengths), the DASS-21 may reflect your experience more accurately -- or vice versa. Discuss both results with your provider.

The bottom line

The PHQ-9 and DASS-21 are both good tools, but they serve different purposes. The PHQ-9 is a focused depression screener built for clinical decision-making: it maps to DSM criteria, includes suicidal ideation screening, and has clear treatment thresholds. The DASS-21 is a broad emotional assessment that separates depression, anxiety, and stress into three distinct dimensions.

Choose the PHQ-9 for clinical depression screening and treatment monitoring. Choose the DASS-21 when you need the broader emotional picture or when the patient's presentation is mixed. And when in doubt, consider that five extra minutes with both tools gives you substantially more information than either one alone.

Track your mental health

Create a free account to access validated assessments with automatic scoring and progress tracking

Create free account
This platform provides mental health screening tools for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult with qualified healthcare providers for mental health concerns.